Thyroid Dysfunction with Targeted Chemotherapy Agents
1. Evaluate the mechanisms by which hyperglycemia and hypothyroidism occur in patients on certain targeted chemotherapy agents.2. Develop treatment recommendations for patients who develop these endocrine toxicities while on therapy.3. Establish appropriate monitoring guidelines for patient receiving certain targeted chemotherapy agents.
Bossaer, John B.. 2012. Thyroid Dysfunction with Targeted Chemotherapy Agents. Accreditation Council for Pharmaceutical Education (ACPE) accredited presentation. American College of Clinical Pharmacy (ACCP) Annual Meeting, Hollywood, FL. https://www.accp.com/meetings/am12/schedule.aspx?mode=detail&i=2856